Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 98

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Regulatory Role of Nitric Oxide in Cutaneous Inflammation

Man, Mao-Qiang, Wakefield, Joan S., Mauro, Theodora M., Elias, Peter M. · 2022 · Inflammation

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10753-021-01615-8

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 131

  1. Massion, P.B., O. Feron, C. Dessy, and J.L. Balligand. 2003. Nitric oxide and cardiac function: Ten years after, and continuing. Circulation Research 93 (5): 388–398. · DOI · Paper page
  2. Musialek, P., M. Lei, H.F. Brown, D.J. Paterson, and B. Casadei. 1997. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, I(f). Circulation Research 81 (1): 60–68. · DOI · Paper page
  3. Shesely, E.G., N. Maeda, H.S. Kim, K.M. Desai, J.H. Krege, V.E. Laubach, P.A. Sherman, W.C. Sessa, and O. Smithies. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the USA 93 (23): 13176–13181. · DOI · Paper page
  4. Miyamoto, Y., Y. Saito, N. Kajiyama, M. Yoshimura, Y. Shimasaki, M. Nakayama, S. Kamitani, M. Harada, M. Ishikawa, K. Kuwahara, E. Ogawa, I. Hamanaka, N. Takahashi, T. Kaneshige, H. Teraoka, T. Akamizu, N. Azuma, Y. Yoshimasa, T. Yoshimasa, H. Itoh, I. Masuda, H. Yasue, and K. Nakao. 1998. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32 (1): 3–8. · DOI · Paper page
  5. Cau, S.B., F.S. Carneiro, and R.C. Tostes. 2012. Differential modulation of nitric oxide synthases in aging: Therapeutic opportunities. Frontiers in Physiology 3: 218.
  6. Liu, Y.H., O.A. Carretero, O.H. Cingolani, T.D. Liao, Y. Sun, J. Xu, L.Y. Li, P.J. Pagano, J.J. Yang, and X.P. Yang. 2005. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology 289: H2616–H2623. · DOI
  7. Iwakiri, Y., and M.Y. Kim. 2015. Nitric oxide in liver diseases. Trends in Pharmacological Sciences 36 (8): 524–536. · DOI · Paper page
  8. Mahmoud, M.F., S. Zakaria, and A. Fahmy. 2015. Can chronic nitric oxide inhibition improve liver and renal dysfunction in bile duct ligated rats? Advances in Pharmacological Sciences 2015:298792. · doi:10.1155/2015/298792
  9. Weinberger, B., D.E. Heck, D.L. Laskin, and J.D. Laskin. 1999. Nitric oxide in the lung: Therapeutic and cellular mechanisms of action. Pharmacology & Therapeutics 84 (3): 401–411. · DOI
  10. Kinsella, J.P., T.A. Parker, H. Galan, B.C. Sheridan, A.C. Halbower, and S.H. Abman. 1997. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatric Research 41 (4 Pt 1): 457–463. · doi:10.1203/00006450-199704000-00002
  11. Kozłowska, Z., Z. Owsiańska, J.P. Wroblewska, et al. 2020. Genotype-phenotype correlation in two Polish neonates with alveolar capillary dysplasia. BMC Pediatrics 20 (1): 320. · doi:10.1186/s12887-020-02200-y
  12. Ramirez, L.A., E.E. Gillis, J.B. Musall, R. Mohamed, E. Snyder, A. El-Marakby, and J.C. Sullivan. 2020. Hypertensive female Sprague-Dawley rats require an intact nitric oxide synthase system for compensatory increases in renal regulatory T cells. American Journal of Physiology Renal Physiology 319 (2): F192–F201. · DOI
  13. Brinson, K.N., A.A. Elmarakby, A.J. Tipton, G.R. Crislip, T. Yamamoto, B. Baban, and J.C. Sullivan. 2013. Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 305 (7): R701–R710.
  14. Zhan, R., S. Yang, W. He, F. Wang, J. Tan, J. Zhou, S. Yang, Z. Yao, J. Wu, and G. Luo. 2015. Nitric oxide enhances keratinocyte cell migration by regulating Rho GTPase via cGMP-PKG signalling. PLoS One 10(3):e0121551. · DOI
  15. Malone-Povolny, M.J., S.E. Maloney, and M.H. Schoenfisch. 2019. Nitric oxide therapy for diabetic wound healing. Advanced Healthcare Materials 8(12):e1801210. · DOI · Paper page
  16. Witte, M.B., T. Kiyama, and A. Barbul. 2002. Nitric oxide enhances experimental wound healing in diabetes. British Journal of Surgery 89 (12): 1594–1601. · DOI · Paper page
  17. Shi, H.P., S.M. Wang, G.X. Zhang, Y.J. Zhang, and A. Barbul. 2007. Supplemental L-arginine enhances wound healing following trauma/hemorrhagic shock. Wound Repair Regen. 15 (1): 66–70. · doi:10.1111/j.1524-475x.2006.00186.x
  18. Krischel, V., D. Bruch-Gerharz, C. Suschek, K.D. Kröncke, T. Ruzicka, and V. Kolb-Bachofen. 1998. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. The Journal of Investigative Dermatology 111 (2): 286–291. · DOI · Paper page
  19. Kitano, T., H. Yamada, M. Kida, Y. Okada, S. Saika, and M. Yoshida. 2017. Impaired healing of a cutaneous wound in an inducible nitric oxide synthase-knockout mouse. Dermatology Research and Practice 2017: 2184040. · DOI
  20. Dang, E., G. Man, J. Zhang, D. Lee, T.M. Mauro, P.M. Elias, and M.Q. Man. 2020. Inducible nitric oxide synthase is required for epidermal permeability barrier homeostasis in mice. Experimental Dermatology 29 (10): 1027–1032. · DOI
  21. Man, M.Q., J.S. Wakefield, T.M. Mauro, and P.M. Elias. 2021. Role of nitric oxide in regulating epidermal permeability barrier function. Experimental Dermatology https://doi.org/10.1111/exd.14470 · DOI
  22. Mihu, M.R., U. Sandkovsky, G. Han, J.M. Friedman, J.D. Nosanchuk, and L.R. Martinez. 2010. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence. 1 (2): 62–67. · DOI
  23. Martinez, L.R., G. Han, M. Chacko, M.R. Mihu, M. Jacobson, P. Gialanella, A.J. Friedman, J.D. Nosanchuk, and J.M. Friedman. 2009. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. The Journal of Investigative Dermatology 129: 2463–2469. · DOI · Paper page
  24. Ghaffari, A., R. Jalili, M. Ghaffari, C. Miller, and A. Ghahary. 2007. Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. Wound Repair Regen. 15: 368–377. · DOI
  25. Wallace, J.L. 2005. Nitric oxide as a regulator of inflammatory processes. Memorias do Instituto Oswaldo Cruz 100: S5-9. · DOI
  26. Moilanen, E., and H. Vapaatalo. 1995. Nitric oxide in inflammation and immune response. Annals of Medicine 27 (3): 359–367. · DOI · Paper page
  27. Medeiros, R., C.P. Figueiredo, G.F. Passos, and J.B. Calixto. 2009. Reduced skin inflammatory response in mice lacking inducible nitric oxide synthase. Biochemical Pharmacology 78 (4): 390–395. · DOI
  28. Stuehr, D., S. Pou, and G.M. Rosen. 2001. Oxygen reduction by nitric-oxide synthases. Journal of Biological Chemistry 276 (18): 14533–14536. · DOI · Paper page
  29. Förstermann, U., and W.C. Sessa. 2012. Nitric oxide synthases: regulation and function. European Heart Journal 33(7):829–37, 837a-837d. · DOI · Paper page
  30. Förstermann, U., and H. Kleinert. 1995. Nitric oxide synthase: Expression and expressional control of the three isoforms. Naunyn-Schmiedeberg’s Archives of Pharmacology 352 (4): 351–364. · DOI · Paper page
  31. Mattila, J.T., and A.C. Thomas. 2014. Nitric oxide synthase: Non-canonical expression patterns. Frontiers in Immunology 5: 478. · DOI · Paper page
  32. Jianjun Yang, J., R. Zhang, G. Lu, Y. Shen, L. Peng, C. Zhu, M. Cui, W. Wang, P. Arnaboldi, M. Tang, M. Gupta, C.F. Qi, P. Jayaraman, H. Zhu, B. Jiang, S.H. Chen, J.C. He, A.T. Ting, M.M. Zhou, V.K. Kuchroo, H.C. Morse 3rd., K. Ozato, A.G. Sikora, and H. Xiong. 2013. T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. Journal of Experimental Medicine 210 (7): 1447–1462. · DOI
  33. Gilchrist, M., S.D. McCauley, and A.D. Befus. 2004. Expression, localization, and regulation of NOS in human mast cell lines: Effects on leukotriene production. Blood 104 (2): 462–469. · DOI
  34. Devika, N.T., and B.M. Jaffar Ali. 2013. Analysing calcium dependent and independent regulation of eNOS in endothelium triggered by extracellular signaling events. Molecular BioSystems 9: 2653–2664. · DOI
  35. Förstermann, U., J.P. Boissel, and H. Kleinert. 1998. Expressional control of the “constitutive” isoforms of nitric oxide synthase (NOS I and NOS III). The FASEB Journal 12 (10): 773–790. · DOI · Paper page
  36. Herdegen, T., S. Brecht, B. Mayer, J. Leah, W. Kummer, R. Bravo, and M. Zimmermann. 1993. Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. Journal of Neuroscience 13 (10): 4130–4145. · DOI · Paper page
  37. Villar, M.J., S. Ceccatelli, K. Bedecs, T. Bartfai, D. Bredt, S.H. Synder, T Hökfelt. 1994. Upregulation of nitric oxide synthase and galanin message-associated peptide in hypothalamic magnocellular neurons after hypophysectomy. Immunohistochemical and in situ hybridization studies. Brain Research 650(2):219–28. · DOI
  38. Zhang, Z.G., M. Chopp, S. Gautam, C. Zaloga, R.L. Zhang, H.H. Schmidt, J.S. Pollock, and U. Förstermann. 1994. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Research 654 (1): 85–95. · DOI · Paper page
  39. Boissel, J.P., D. Ohly, M. Bros, U. Gödtel-Armbrust, U. Förstermann, and S. Frank. 2004. The neuronal nitric oxide synthase is upregulated in mouse skin repair and in response to epidermal growth factor in human HaCaT keratinocytes. The Journal of Investigative Dermatology 123 (1): 132–139. · DOI
  40. Kaku, Y., H. Nanri, T. Sakimura, K. Ejima, A. Kuroiwa, and M. Ikeda. 1997. Differential induction of constitutive and inducible nitric oxide synthases by distinct inflammatory stimuli in bovine aortic endothelial cells. Biochimica et Biophysica Acta 1356 (1): 43–52. · DOI
  41. Bucher, M., K.P. Ittner, M. Zimmermann, K. Wolf, J. Hobbhahn, and A. Kurtz. 1997. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Letters 412 (3): 511–514. · DOI
  42. Neugarten, J., Q. Ding, A. Friedman, J. Lei, and S. Silbiger. 1997. Sex hormones and renal nitric oxide synthases. Journal of the American Society of Nephrology 8 (8): 1240–1246. · DOI
  43. Lantin-Hermoso, R.L., C.R. Rosenfeld, I.S. Yuhanna, Z. German, Z. Chen, and P.W. Shaul. 1997. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. American Journal of Physiology 273 (1 Pt 1): L119–L126.
  44. Ikeyama, K., S. Denda, M. Tsutsumi, and M. Denda. 2010. Neuronal nitric oxide synthase in epidermis is involved in cutaneous circulatory response to mechanical stimulation. The Journal of Investigative Dermatology 130 (4): 1158–1166. · doi:10.1038/jid.2009.350
  45. Zhang, B., W. Crankshaw, R. Nesemeier, J. Patel, I. Nweze, J. Lakshmanan, and B.G. Harbrecht. 2015. Calcium-mediated signaling and calmodulin-dependent kinase regulate hepatocyte-inducible nitric oxide synthase expression. Journal of Surgical Research 193 (2): 795–801. · DOI
  46. Pautz, A., J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert. 2010. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23 (2): 75–93. · DOI · Paper page
  47. Arany, I., M.M. Brysk, H. Brysk, and S.K. Tyring. 1996. Induction of iNOS mRNA by interferon-gamma in epithelial cells is associated with growth arrest and differentiation. Cancer Letters 110 (1–2): 93–96. · doi:10.1016/s0304-3835(96)04476-x
  48. Linehan, J.D., G. Kolios, V. Valatas, D.A. Robertson, and J. Westwick. 2005. Immunomodulatory cytokines suppress epithelial nitric oxide production in inflammatory bowel disease by acting on mononuclear cells. Free Radical Biology & Medicine 39 (12): 1560–1569. · doi:10.1016/j.freeradbiomed.2005.07.019
  49. Taub, D.D., and G.W. Cox. 1995. Murine Th1 and Th2 cell clones differentially regulate macrophage nitric oxide production. Journal of Leukocyte Biology 58 (1): 80–89. · DOI
  50. Saha, R.N., and K. Pahan. 2006. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxidants & Redox Signaling 8 (5–6): 929–947. · DOI · Paper page
  51. Wienerroither, S., I. Rauch, F. Rosebrock, A.M. Jamieson, J. Bradner, M. Muhar, J. Zuber, M. Müller, and T. Decker. 2014. Regulation of NO synthesis, local inflammation, and innate immunity to pathogens by BET family proteins. Molecular and Cellular Biology 34 (3): 415–427. · DOI
  52. Holliman, G., D. Lowe, H. Cohen, S. Felton, and K. Raj. 2017. Ultraviolet radiation-induced production of nitric oxide: A multi-cell and multi-donor analysis. Science and Reports 7 (1): 11105. · DOI
  53. Chang, H.R., D.A. Tsao, S.R. Wang, and H.S. Yu. 2003. Expression of nitric oxide synthases in keratinocytes after UVB irradiation. Archives of Dermatological Research 295 (7): 293–296. · DOI
  54. Rafa, H., H. Saoula, M. Belkhelfa, O. Medjeber, I. Soufli, R. Toumi, Y. de Launoit, O. Moralès, M. Nakmouche, N. Delhem, and C. Touil-Boukoffa. 2013. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: Immunomodulatory effect of retinoic acid. Journal of Interferon and Cytokine Research 33 (7): 355–368. · DOI
  55. Rafa, H., M. Amri, H. Saoula, M. Belkhelfa, O. Medjeber, A. Boutaleb, S. Aftis, M. Nakmouche, and C. Touil-Boukoffa. 2010. Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: A study in Algerian patients. Journal of Interferon and Cytokine Research 30 (9): 691–697. · DOI
  56. Kankuri, E., K. Vaali, R.G. Knowles, M. Lähde, R. Korpela, H. Vapaatalo, and E. Moilanen. 2001. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine. Journal of Pharmacology and Experimental Therapeutics 298 (3): 1128–1132.
  57. Kankuri, E., M. Hämäläinen, M. Hukkanen, P. Salmenperä, E. Kivilaakso, H. Vapaatalo, and E. Moilanen. 2003. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scandinavian Journal of Gastroenterology 38 (2): 186–192. · DOI
  58. Demirel, I., R. Vumma, C. Mohlin, L. Svensson, S. Säve, and K. Persson. 2012. Nitric oxide activates IL-6 production and expression in human renal epithelial cells. American Journal of Nephrology 36 (6): 524–530. · DOI
  59. Raykova, V.D., M. Glibetic, J.P. Ofenstein, and J.V. Aranda. 2003. Nitric oxide-dependent regulation of pro-inflammatory cytokines in group B streptococcal inflammation of rat lung. Annals of Clinical and Laboratory Science 33 (1): 62–67.
  60. Holán, V., M. Krulová, A. Zajícová, and J. Pindjáková. 2002. Nitric oxide as a regulatory and effector molecule in the immune system. Molecular Immunology 38 (12–13): 989–995. · DOI
  61. Hsu, C.C., C.L. Lin, I.M. Jou, P.H. Wang, and J.S. Lee. 2017. The protective role of nitric oxide-dependent innate immunosuppression in the early stage of cartilage damage in rats: Role of nitric oxide in cartilage damage. Bone & Joint Research 6 (4): 253–258. · DOI
  62. Bécherel, P.A., M.D. Mossalayi, F. Ouaaz, L. Le Goff, B. Dugas, N. Paul-Eugène, C. Frances, O. Chosidow, E. Kilchherr, J.J. Guillosson, et al. 1994. Involvement of cyclic AMP and nitric oxide in immunoglobulin e-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes. The Journal of Clinical Investigation 93 (5): 2275–2279. · DOI
  63. Chun, K.S., H.H. Cha, J.W. Shin, H.K. Na, K.K. Park, W.Y. Chung, and Y.J. Surh. 2004. Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 25 (3): 445–454. · DOI
  64. Ianaro, A., C.A. O’Donnell, M. Di Rosa, and F.Y. Liew. 1994. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82 (3): 370–375.
  65. Ialenti, A., A. Ianaro, S. Moncada, and M. Di Rosa. 1992. Modulation of acute inflammation by endogenous nitric oxide. European Journal of Pharmacology 211 (2): 177–182. · DOI · Paper page
  66. Salvemini, D., Z.Q. Wang, P.S. Wyatt, D.M. Bourdon, M.H. Marino, P.T. Manning, and M.G. Currie. 1996. Nitric oxide: A key mediator in the early and late phase of carrageenan-induced rat paw inflammation. British Journal of Pharmacology 118 (4): 829–838. · DOI · Paper page
  67. Medeiros, M.V., I.M. Binhara, H. Moreno Júnior, R. Zatz, G. De Nucci, and E. Antunes. 1995. Effect of chronic nitric oxide synthesis inhibition on the inflammatory responses induced by carrageenin in rats. European Journal of Pharmacology 285 (2): 109–114. · doi:10.1016/0014-2999(95)00332-f
  68. Toriyabe, M., K. Omote, T. Kawamata, and A. Namiki. 2004. Contribution of interaction between nitric oxide and cyclooxygenases to the production of prostaglandins in carrageenan-induced inflammation. Anesthesiology 101 (4): 983–990. · DOI
  69. Hughes, S.R., T.J. Williams, and S.D. Brain. 1990. Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. European Journal of Pharmacology 191 (3): 481–484. · DOI · Paper page
  70. Lippe, I.T., A. Stabentheiner, and P. Holzer. 1993. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin. European Journal of Pharmacology 232 (1): 113–120. · doi:10.1016/0014-2999(93)90735-z
  71. Lippe, I.T., A. Stabentheiner, and P. Holzer. 1993. Role of nitric oxide in the vasodilator but not exudative component of mustard oil-induced inflammation in rat skin. Agents Actions 38 Spec No:C22–4. · doi:10.1007/bf01991125
  72. Benrath, J., C. Eschenfelder, M. Zimmerman, and F. Gillardon. 1995. Calcitonin gene-related peptide, substance P and nitric oxide are involved in cutaneous inflammation following ultraviolet irradiation. European Journal of Pharmacology 293 (1): 87–96. · DOI
  73. Warren, J.B., R.K. Loi, and M.L. Coughlan. 1993. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. British Journal of Pharmacology 109 (3): 802–806. · DOI
  74. Chen, Y., M.K. Boettger, A. Reif, A. Schmitt, N. Uçeyler, and C. Sommer. 2010. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Molecular Pain 6: 13.
  75. Mariani-Pedroso, S.R., L. Bizeto, E. Antunes, R. Zatz, and G. de Nucci. 1995. Dissimilarity between prostaglandin E1 and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo. Prostaglandins Leukotrienes and Essential Fatty Acids 52 (6): 399–402. · doi:10.1016/0952-3278(95)90068-3
  76. Teixeira, M.M., T.J. Williams, and P.G. Hellewell. 1993. Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin. British Journal of Pharmacology 110 (4): 1515–1521. · DOI
  77. Teixeira, M.M., S.M. Fairbairn, K.E. Norman, T.J. Williams, A.G. Rossi, and P.G. Hellewell. 1994. Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: Contribution of neutrophils and endogenous mediators. British Journal of Pharmacology 113 (4): 1363–1371. · doi:10.1111/j.1476-5381.1994.tb17148.x
  78. Muangman, P., R.N. Tamura, L.A. Muffley, F.F. Isik, J.R. Scott, C. Xie, G. Kegel, S.R. Sullivan, Z. Liang, and N.S. Gibran. 2009. Substance P enhances wound closure in nitric oxide synthase knockout mice. Journal of Surgical Research 153 (2): 201–209. · DOI
  79. Most, D., D.T. Efron, H.P. Shi, U.S. Tantry, and A. Barbul. 2002. Characterization of incisional wound healing in inducible nitric oxide synthase knockout mice. Surgery. 132 (5): 866–876. · DOI
  80. Ross, R., C. Gillitzer, R. Kleinz, J. Schwing, H. Kleinert, U. Förstermann, and A.B. Reske-Kunz. 1998. Involvement of NO in contact hypersensitivity. International Immunology 10 (1): 61–69. · DOI
  81. Orita, K., K. Hiramoto, H. Kobayashi, M. Ishii, A. Sekiyama, and M. Inoue. 2011. Inducible nitric oxide synthase (iNOS) and α-melanocyte-stimulating hormones of iNOS origin play important roles in the allergic reactions of atopic dermatitis in mice. Experimental Dermatology 20 (11): 911–914. · DOI
  82. Morita, H., M. Hori, and Y. Kitano. 1996. Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide. The Journal of Investigative Dermatology 107 (4): 549–552. · doi:10.1111/1523-1747.ep12582805
  83. Morita, H., M. Semma, M. Hori, and Y. Kitano. 1995. Clinical application of nitric oxide synthase inhibitor for atopic dermatitis. International Journal of Dermatology 34 (4): 294–295. · doi:10.1111/j.1365-4362.1995.tb01602.x
  84. Mowbray, M., X. Tan, P.S. Wheatley, A.G. Rossi, R.E. Morris, and R.B. Weller. 2008. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. The Journal of Investigative Dermatology 128 (2): 352–360. · DOI
  85. Ormerod, A.D., P. Copeland, I. Hay, A. Husain, and S.W. Ewen. 1999. The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. The Journal of Investigative Dermatology 113 (3): 392–397. · DOI
  86. Sugita, K., K. Kabashima, R. Yoshiki, A. Ikenouchi-Sugita, M. Tsutsui, J. Nakamura, N. Yanagihara, and Y. Tokura. 2010. Inducible nitric oxide synthase downmodulates contact hypersensitivity by suppressing dendritic cell migration and survival. The Journal of Investigative Dermatology 130 (2): 464–471. · DOI
  87. Hyun, E., M. Bolla, M. Steinhoff, J.L. Wallace, P.D. Soldato, and N. Vergnolle. 2004. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. British Journal of Pharmacology 143 (5): 618–625. · DOI
  88. Guttman-Yassky, E., R.L. Gallo, A.B. Pavel, T. Nakatsuji, R. Li, N. Zhang, E. Messersmith, and T. Maeda-Chubachi. 2020. A nitric oxide-releasing topical medication as a potential treatment option for atopic dermatitis through antimicrobial and anti-inflammatory activity. The Journal of Investigative Dermatology 140 (12): 2531-2535.e2. · DOI
  89. Kuroishi, T., K. Bando, Y. Endo, and S. Sugawara. 2013. Metal allergens induce nitric oxide production by mouse dermal fibroblasts via the hypoxia-inducible factor-2α-dependent pathway. Toxicological Sciences 135 (1): 119–128. · DOI
  90. Cassini-Vieira, P., F.A. Araújo, F.L. da Costa Dias, R.C. Russo, S.P. Andrade, M.M. Teixeira, and L.S. Barcelos, 2015. iNOS activity modulates inflammation, angiogenesis, and tissue fibrosis in polyether-polyurethane synthetic implants. Mediators Inflammation 2015:138461. · DOI
  91. Kuchel, J.M., R.S. Barnetson, and G.M. Halliday. 2003. Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans. The Journal of Investigative Dermatology 121 (3): 587–593. · DOI
  92. Rowe, A., A.M. Farrell, and C.B. Bunker. 1997. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. British Journal of Dermatology 136 (1): 18–23. · doi:10.1111/j.1365-2133.1997.tb08740.x
  93. Bruch-Gerharz, D., K. Fehsel, C. Suschek, G. Michel, T. Ruzicka, and V. Kolb-Bachofen. 1996. A proinflammatory activity of interleukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. Journal of Experimental Medicine 184 (5): 2007–2012. · DOI · Paper page
  94. Ormerod, A.D., R. Weller, P. Copeland, N. Benjamin, S.H. Ralston, P. Grabowksi, and R. Herriot. 1998. Detection of nitric oxide and nitric oxide synthases in psoriasis. Archives of Dermatological Research 290 (1–2): 3–8. · DOI
  95. Sirsjö, A., M. Karlsson, A. Gidlöf, O. Rollman, and H. Törmä. 1996. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. British Journal of Dermatology 134 (4): 643–648. · DOI
  96. Orem, A., R. Aliyazicioglu, E. Kiran, B. Vanizor, G. Cimnocodeit, and O. Deger. 1997. The relationship between nitric oxide production and activity of the disease in patients with psoriasis. Archives of Dermatology 133 (12): 1606–1607. · doi:10.1001/archderm.133.12.1606
  97. Paul-Clark, M.J., D.W. Gilroy, D. Willis, D.A. Willoughby, and A. Tomlinson. 2001. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. The Journal of Immunology 166 (2): 1169–1177. · DOI · Paper page
  98. Iwama, D., S. Miyahara, H. Tamura, K. Miyamoto, F. Hirose, and N. Yoshimura. 2008. Lack of inducible nitric oxide synthases attenuates leukocyte-endothelial cell interactions in retinal microcirculation. British Journal of Ophthalmology 92 (5): 694–698. · DOI
  99. Sautebin, L., A. Ialenti, A. Ianaro, and M. Di Rosa. 1995. Endogenous nitric oxide increases prostaglandin biosynthesis in carrageenin rat paw oedema. European Journal of Pharmacology 286 (2): 219–222. · doi:10.1016/0014-2999(95)00581-5
  100. Sautebin, L., A. Ialenti, A. Ianaro, and M. Di Rosa. 1995. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. British Journal of Pharmacology 114 (2): 323–328. · DOI
  101. Paul, W., G.J. Douglas, L. Lawrence, A.M. Khawaja, A.C. Perez, M. Schachter, and C.P. Page. 1994. Cutaneous permeability responses to bradykinin and histamine in the guinea-pig: Possible differences in their mechanism of action. British Journal of Pharmacology 111 (1): 159–164. · DOI
  102. Andrew, P.J., H. Harant, and I.J. Lindley. 1995. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochemical and Biophysical Research Communications 214 (3): 949–956. · DOI
  103. Sparkman, L., and V. Boggaram. 2004. Nitric oxide increases IL-8 gene transcription and mRNA stability to enhance IL-8 gene expression in lung epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 287 (4): L764–L773. · DOI
  104. Kobayashi, Y. 2010. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. Journal of Leukocyte Biology 88 (6): 1157–1162. · DOI · Paper page
  105. Corriveau, C.C., P.J. Madara, A.L. Van Dervort, M.M. Tropea, R.A. Wesley, and R.L. Danner. 1998. Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils. Journal of Infectious Diseases 177 (1): 116–126. · doi:10.1086/513829
  106. Van Dervort, A.L., L. Yan, P.J. Madara, J.P. Cobb, R.A. Wesley, C.C. Corriveau, M.M. Tropea, and R.L. Danner. 1994. Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. The Journal of Immunology 152 (8): 4102–4109. · DOI
  107. Baig, M.S., S.V. Zaichick, M. Mao, A.L. de Abreu, F.R. Bakhshi, P.C. Hart, U. Saqib, J. Deng, S. Chatterjee, M.L. Block, S.M. Vogel, A.B. Malik, M.E. Consolaro, J.W. Christman, R.D. Minshall, B.N. Gantner, and M.G. Bonini. 2015. NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1. Journal of Experimental Medicine 212 (10): 1725–1738. · DOI
  108. Niedbala W, B. Cai, and F.Y. Liew. 2006. Role of nitric oxide in the regulation of T cell functions. Annals of the Rheumatic Diseases 65(Suppl 3):iii37–40. · DOI · Paper page
  109. Granger, D.N., and P. Kubes. 1996. Nitric oxide as antiinflammatory agent. Methods in Enzymology 269: 434–442. · DOI
  110. Gaboury, J., R.C. Woodman, D.N. Granger, P. Reinhardt, and P. Kubes. 1993. Nitric oxide prevents leukocyte adherence: Role of superoxide. American Journal of Physiology 265 (3 Pt 2): H862–H867.
  111. Kubes, P., I. Kurose, and D.N. Granger. 1994. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. American Journal of Physiology 267 (3 Pt 2): H931–H937.
  112. Wallace, J.L., N. Vergnolle, M.N. Muscará, S. Asfaha, K. Chapman, W. McKnight, P. Del Soldato, A. Morelli, and S. Fiorucci. 1999. Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology 117 (3): 557–566. · DOI
  113. Qin, M., A. Landriscina, J.M. Rosen, G. Wei, S. Kao, W. Olcott, G.W. Agak, K.B. Paz, J. Bonventre, A. Clendaniel, S. Harper, B.L. Adler, A.E. Krausz, J.M. Friedman, J.D. Nosanchuk, J. Kim, and A.J. Friedman. 2015. Nitric oxide-releasing nanoparticles prevent Propionibacterium acnes-induced inflammation by both clearing the organism and inhibiting microbial stimulation of the innate immune response. The Journal of Investigative Dermatology 135 (11): 2723–2731. · DOI
  114. Qin, M., A. Pirouz, M.H. Kim, S.R. Krutzik, H.J. Garbán, and J. Kim. 2014. Propionibacterium acnes induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. The Journal of Investigative Dermatology 134 (2): 381–388. · DOI · Paper page
  115. Bauernfeind, F.G., G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, T. Fernandes-Alnemri, J. Wu, B.G. Monks, K.A. Fitzgerald, V. Hornung, and E. Latz. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. The Journal of Immunology 183 (2): 787–791. · DOI · Paper page
  116. Kistowska, M., S. Gehrke, D. Jankovic, K. Kerl, A. Fettelschoss, L. Feldmeyer, G. Fenini, A. Kolios, A. Navarini, R. Ganceviciene, J. Schauber, E. Contassot, and L.E. French. 2014. IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo. The Journal of Investigative Dermatology 134 (3): 677–685. · DOI · Paper page
  117. Li, Z.J., D.K. Choi, K.C. Sohn, M.S. Seo, H.E. Lee, Y. Lee, Y.J. Seo, Y.H. Lee, G. Shi, C.C. Zouboulis, C.D. Kim, J.H. Lee, and M. Im. 2014. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. The Journal of Investigative Dermatology 134 (11): 2747–2756. · DOI
  118. Hernandez-Cuellar, E., K. Tsuchiya, H. Hara, R. Fang, S. Sakai, I. Kawamura, S. Akira, and M. Mitsuyama. 2012. Cutting edge: Nitric oxide inhibits the NLRP3 inflammasome. The Journal of Immunology 189 (11): 5113–5117. · DOI · Paper page
  119. Wishah, K., A. Malur, B. Raychaudhuri, A.L. Melton, M.S. Kavuru, and M.J. Thomassen. 2002. Nitric oxide blocks inflammatory cytokine secretion triggered by CD23 in monocytes from allergic, asthmatic patients and healthy controls. Annals of Allergy, Asthma & Immunology 89 (1): 78–82. · DOI
  120. Dinakar, C., A. Malur, B. Raychaudhuri, L.T. Buhrow, A.L. Melton, M.S. Kavuru, and M.J. Thomassen. 1999. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Annals of Allergy, Asthma & Immunology 82 (2): 217–222. · DOI
  121. Persoons, J.H., K. Schornagel, F.F. Tilders, J. De Vente, F. Berkenbosch, and G. Kraal. 1996. Alveolar macrophages autoregulate IL-1 and IL-6 production by endogenous nitric oxide. American Journal of Respiratory Cell and Molecular Biology 14 (3): 272–278. · doi:10.1165/ajrcmb.14.3.8845178
  122. Qiu, H.B., D.C. Chen, J.Q. Pan, D.W. Liu, and S. Ma. 1999. Inhibitory effects of nitric oxide and interleukin-10 on production of tumor necrosis factor alpha, interleukin-1 beta, and interleukin-6 in mouse alveolar macrophages. Zhongguo Yao Li Xue Bao 20 (3): 271–275.
  123. Deakin, A.M., A.N. Payne, B.J. Whittle, and S. Moncada. 1995. The modulation of IL-6 and TNF-alpha release by nitric oxide following stimulation of J774 cells with LPS and IFN-gamma. Cytokine 7 (5): 408–416. · DOI
  124. Yu, C., A. Fitzpatrick, D. Cong, C. Yao, J. Yoo, A. Turnbull, J. Schwarze, M. Norval, S.E.M. Howie, R.B. Weller, and A.L. Astier. 2017. Nitric oxide induces human CLA+CD25+Foxp3+ regulatory T cells with skin-homing potential. The Journal of Allergy and Clinical Immunology 140 (5): 1441-1444.e6. · DOI
  125. Allione, A., P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli. 1999. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. The Journal of Immunology 163 (8): 4182–4191. · DOI
  126. Ialenti, A., A. Ianaro, P. Maffia, L. Sautebin, and M. Di Rosa. 2000. Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflammation Research 49 (8): 411–417. · DOI
  127. Dal Secco, D., A.P. Moreira, A. Freitas, J.S. Silva, M.A. Rossi, S.H. Ferreira, and F.Q. Cunha. 2006. Nitric oxide inhibits neutrophil migration by a mechanism dependent on ICAM-1: Role of soluble guanylate cyclase. Nitric Oxide 15 (1): 77–86. · DOI
  128. Vallance, P., and A. Hingorani. 1999. Endothelial nitric oxide in humans in health and disease. International Journal of Experimental Pathology 80 (6): 291–303. · DOI
  129. Armstrong, R. 2001. The physiological role and pharmacological potential of nitric oxide in neutrophil activation. International Immunopharmacology 1 (8): 1501–1512. · DOI
  130. Tripathi, P. 2007. Nitric oxide and immune response. Indian Journal of Biochemistry & Biophysics 44 (5): 310–319.
  131. Coleman, J.W. 2002. Nitric oxide: A regulator of mast cell activation and mast cell-mediated inflammation. Clinical and Experimental Immunology 129 (1): 4–10. · DOI · Paper page

Cited by

See all 98

Metadata

Authors
Man, M.-Q., Wakefield, J. S., Mauro, T. M., & Elias, P. M.
Venue
Inflammation
Published
2022-01-30
Volume
45
Issue
3
Pages
949-964
ISSN
  • 0360-3997
  • 1573-2576
Cited by
98
References
4
Language
en
Licence
Funders
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061106)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulatory Role of Nitric Oxide in Cutaneous Inflammation. https://app.cochat.ai/papers/10.1007/s10753-021-01615-8
The paper
Man, M.-Q., Wakefield, J. S., Mauro, T. M., & Elias, P. M. (2022). Regulatory Role of Nitric Oxide in Cutaneous Inflammation. Inflammation. https://doi.org/10.1007/s10753-021-01615-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.